ProfileGDS4718 / 208289_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 91% 89% 91% 90% 91% 94% 93% 90% 87% 92% 92% 85% 93% 95% 93% 93% 91% 95% 94% 88% 90% 90% 91% 91% 92% 94% 90% 94% 88% 92% 94% 91% 89% 88% 93% 93% 91% 91% 89% 89% 90% 93% 89% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.4994991
GSM549102patient 115, normal, homogenized [OPG study]9.0137389
GSM549104patient 119, normal, homogenized [OPG study]9.4048191
GSM549108patient 138, normal, homogenized [OPG study]9.1877190
GSM549119patient 077, normal, homogenized [OPG study]9.3692291
GSM549133patient 032, cancer, homogenized [OPG study]10.090494
GSM549139patient 042, cancer, homogenized [OPG study]9.7686593
GSM549099patient 107, normal, homogenized [OPG study]9.1270790
GSM549109patient 139, normal, homogenized [OPG study]8.6932887
GSM549110patient 046, normal, homogenized [OPG study]9.6197292
GSM549114patient 063, normal, homogenized [OPG study]9.7412392
GSM549122patient 082, normal, homogenized [OPG study]8.4923185
GSM549134patient 033, cancer, homogenized [OPG study]9.8177393
GSM549136patient 036, cancer, homogenized [OPG study]10.180795
GSM549140patient 044, cancer, homogenized [OPG study]9.8595393
GSM549111patient 047, normal, homogenized [OPG study]9.9183693
GSM549113patient 057, normal, homogenized [OPG study]9.6043791
GSM549132patient 031, cancer, homogenized [OPG study]10.042695
GSM549137patient 038, cancer, homogenized [OPG study]9.9979494
GSM549142patient 047, cancer, homogenized [OPG study]8.4503588
GSM549100patient 110, normal, homogenized [OPG study]9.1518190
GSM549107patient 135, normal, homogenized [OPG study]9.341690
GSM549115patient 068, normal, homogenized [OPG study]9.5578591
GSM549116patient 072, normal, homogenized [OPG study]9.5119691
GSM549120patient 078, normal, homogenized [OPG study]9.595292
GSM549131patient 030, cancer, homogenized [OPG study]10.030994
GSM549118patient 074, normal, homogenized [OPG study]9.2841790
GSM549129patient 027, cancer, homogenized [OPG study]9.7182994
GSM549123patient 088, normal, homogenized [OPG study]8.9682888
GSM549124patient 006, cancer, homogenized [OPG study]9.4184292
GSM549126patient 015, cancer, homogenized [OPG study]9.9865994
GSM549128patient 025, cancer, homogenized [OPG study]9.3253291
GSM549103patient 117, normal, homogenized [OPG study]9.0173289
GSM549117patient 073, normal, homogenized [OPG study]9.0512288
GSM549138patient 041, cancer, homogenized [OPG study]9.7177893
GSM549141patient 045, cancer, homogenized [OPG study]9.8415593
GSM549130patient 028, cancer, homogenized [OPG study]9.2968391
GSM549101patient 111, normal, homogenized [OPG study]9.3781991
GSM549105patient 128, normal, homogenized [OPG study]9.0153789
GSM549106patient 134, normal, homogenized [OPG study]9.2656689
GSM549112patient 048, normal, homogenized [OPG study]9.1949890
GSM549125patient 011, cancer, homogenized [OPG study]9.6859893
GSM549127patient 024, cancer, homogenized [OPG study]8.8972989
GSM549135patient 035, cancer, homogenized [OPG study]9.5728592